The production of a number of polypeptide mediators or lymphokines underlies many of the differentiated functions of T lymphocytes including their capacity to influence B cells, macrophages, killer cells, as well as a variety of nonleukocytes. Lympbokine release begins when T cells are stimulated with antigen or mitogen. It quickly ceases when the stimulant is removed. A primary control is at tbe level of gene transcription. The stimulation of resting T cells, or the restimulation of isolated lymphoblasts and T cell lines, induces the formation of active lymphokine mRNA (1) (2) (3) (4) (5) .
Evidence that lymphokine mRNA levels are subject to distinct controls has come fi'om studies of the immunosuppressive drug, cyclosporin A (CsA)J This cyclic peptide blocks the production of several lymphokines but has minimal effects on the expression and function of the T cell's receptor for growth factor or 1L-2 (IL-2-R) (1, 3) . Several recent studies (1) (2) (3) (4) indicate that the mechanism of action of CsA is to inhibit the synthesis of lymphokine mRNA that is initiated upon addition of mitogens. CsA blocks the production of IL-2 mRNA as assessed by nuclear transcription and northern blotting assays, as well as the mRNAs for several other lymphokines (IFN-3,, B cell-, and cytolytic T cell-stimulating factors) as shown with oocyte translation systems (1) (2) (3) (4) . Another control of lymphokine mRNA appears to be an endogenous protein, which in some way downregulates the level of IL-2 message (6, 7) .
We have used DNA-RNA blotting to further analyze the control oflymphokine mRNA levels. The initial goal was to use a large panel of DNA probes to compare lymphokine and nonlymphokine gene expression in terms of kinetics, mitogen requirements, and sensitivity to CsA. The probes identified the mRNAs for the protooncogenes c-fos, c-myb, and c-myc, the IL-2-R, the lymphokines IL-2 and IFN, and the 70 kD heat shock protein (HSP). The results show that lymphokine and nonlymphokine mRNAs are induced by distinct exogenous stimuli. However, IL-2 and IFN mRNAs share with c-myc certain intracellular controls, including kinetics of mRNA accumulation and sensitivity to CsA. ~Abbreviations used in this paper: CsA, cyclosporine A; CX, cycloheximide; HSP, heat shock protein.
Materials and Methods

Materials.
We purchased leukocyte-rich huffy coats from the New York Blood Center; con A, (crystallized three times) from Miles Laboratories Inc., Elkart, IN; PMA and cycloheximide (CX) from Sigma Chemical Co., St. Louis, MO; PHA from Gibco, Grand Island, NY; OKT3 mAb from Ortho Diagnostics, Raritan, NJ. We were generously supplied with: CsA and CsH by Drs. J. F. Borel and B. Ryffel, Sandoz Pharmaceutical, Basel, Switzerland; purified rIL-2 (1.2 X 106 U/rag) by Dr. S. Rudnick, Biogen, Cambridge, MA; and several DNA probes. Dr. P. Barr (Chiron Corp., Emeryville, CA) provided oligonucleotide probes to IL-2 and IFN-~,. The IL-2 probe was complementary to the 5' region of the IL-2 leader sequence 5'-ATG TAC AGG ATG CAA CTC CTG TCT TGC-3', and the IFN probe complementary to the 3'-untranslated region of sequence 5'-CTG TAC CCA AAT GGA AAG TAA CTC ATT TGT TAA AAT TATC-3'. Alternatively, an IL-2 cDNA, described by Clark et al. (8) was used. cDNA probes for c-fos (9) , c-myc (10), c-myb (1 I), and IL-2-R (12) were provided by Drs. H. Hanafusa, The
Rockefeller University, K. B. Marcu, State University of New York, Stony Brook, NY, Dr. J. M. Bishop, University of California, San Francisco, CA, and Dr. W. Greene, National Institutes of Health, Bethesda, MD, respectively. The origin and specificity of the cDNAs for fl-actin and/3~-microglobulin, have been described (13, 14) , and a description of the 70 kD HSP (HSP-70) is in preparation (L. Andrus).
Cell Cultures. Blood mononuclear cells were obtained by applying 10 ml of buffy coat preparations to 10 ml Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ). For studies of unprimed T cells, mononuclear populations were cultured at 5 x 106 cells/ml in complete medium consisting of RPMI-1640 (Gibco) supplemented with 2% heatinactivated FCS (Sterile Systems, Logan, UT), 20 #g/ml gentamicin sulfate, 5 X 10 -5 M 2-ME, and different mitogens: PMA at 10 ng/ml, and PHA at 1 /~g/ml. For studies of lymphoblasts, we cultured cells at 106 cells/ml for 4-5 d in PHA (1 •g/ml). The cells were collected, washed, counted and plated at 2 x 10 ~ cells/ml in RPMI supplemented with 2% serum to which different stimulants or inhibitors (CsA; CX) were added (see Results). To separate CD4 and CD8 subsets, stimulated nylon wool-nonadherent T cells were coated with OKT4 or OKT8 hybridoma culture supernatant (American Type Culture Collection, Rockville, MD) and centrifuged onto Petri dishes coated with anti-mouse Ig (Jackson Immunochemicals, Avondale, PA). The nonadherent cells were examined by indirect immunofluorescence and found to be depleted of the T cells that were reactive with the panning mAb, and to be highly (>95%) enriched in the reciprocal T4 + or T8 + subset. In most experiments, the mitogens and CsA were applied continuously, but in experiments in which lymphokine release was measured, these agents were applied as a 2-h pulse in serum-free medium. Most cells attached to the dishes in the absence of serum. The mitogens and CsA were removed by washing and the attached cells recultured in medium (above).
RNA Blot (Northern) Analysis. Total cellular RNA was isolated by a guanidine isothiocyanate method (15) with cesium chloride modification (16) , and quantified by absorbance at 260 nm. Samples were denatured at 60°C for 10 min in electrophoresis buffer (20 mM morholinopropane sulfonic acid, 5 mM sodium acetate, 1 mM EDTA, 3% formaldehyde, pH 7.0) containing 50% formamide. RNA was then size-fractionated by electrophoresing through 1% agarose gel containing 6% formaldehyde, then transferred to gene screen filters (New England Nuclear, Boston, MA). Filters were dried, baked at 80°C in vacuo for 2 b, treated at 42°C for t6-20 h with prehybridization solution (50% formamide, Denhardt's solution I0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% BSA], 1% SDS, 1 M NaCI, 50 mM Tris HCI, pH 7.4, 250 #g/ml denatured salmon sperm DNA, and hybridized at 42°C for 24 (17) . Filters were washed twice in 2X NaCl/citrate (300 mM NaCI, 30 mM sodium citrate) for 5 min, twice in 2X NaC1/citrate with 1% SDS at 60°C, and twice at room temperature for 30 rain. Filters were exposed 1-4 d at -70°C to Fuji film using intensifying screens.
Lymphokine Assays. IL-2 activity in conditioned medium was assayed on mouse lyre-phoblasts prepared by stimulating spleen cells 3-4 d with Con A (18). Dilutions of medium (50 ttl) were cultured with 50 ttl of lymphoblasts (4 X 105 cell/ml). After 18-20 h, the cultures were pulsed with 1.7 ttCi [~H]TdR for 4 h. The uptakes we report are from the linear portion of the dose-response curve. IFN was determined by RIA (Centocor, Malvern, PA).
In Vitro Nuclear Transcription Assay. In vitro transcription was performed according to the method of McKnight and Palmiter (19) . Briefly, nuclei (10 s) were isolated and used immediately to prepare nascent RNA transcripts labeled with [s~P]UTP (3,000 Ci/mM; New England Nuclear) for 30 min at 36°C. The nascent RNA transcripts were purified by DNase I (RNase free; 50 ttg/ml; Boehringer Mannheim, Houston, TX) treatment, proteinase K (25 #g/ml; Boehringer Mannheim) digestion, phenol extraction, and ethanol precipitation. The labeled nuclear RNA was then hybridized to excess specific cDNA (10 ttg) immobilized on nitrocellulose filters. Autoradiographic exposures were 2-4 d.
Results
Stimulus Requirements for Optimal Release of L ymphokines.
Lectin-primed blood mononuclear cells proved to be a useful source of T cells for studies of mRNA levels in stimulated T cells. We first confirmed that the requirements for lymphokine release from primed cells were similar to those previously reported for unprimed populations.
Human mononuclear cells were enriched in IL-2-responsive T lymphoblasts by culturing for 4-5 d in PHA. The cells were washed, restimulated for 16 h with a number of stimuli singly or in concert, and assayed for IFN and IL-2 release. Little IL-2 release occurred after challenge with PMA, PHA, or the OKT3 mAb, which reacts with the T3 component of the T cell receptor for antigen/MHC. Low levels of IFN were induced by PMA or PHA. However, the mixture of lectin with PMA (Table I) or OKT3 with PMA (data not shown), were synergistic and induced high levels of lymphokine release. A similar synergism has been reported in studies of iymphokine production by unprimed guinea pig and human T cells, and the human Jurkat T cell line (2, 20, 21) . The immunosuppressive drug CsA (Table I) , but not the inactive analog CsH (not shown), blocked the release of both IL-2 and IFN from T blasts.
IL-2 also induced low levels of IFN release from T blasts (Table I) . This response could not be attributed to NK cells, as reported for unprimed populations (22, 23) , since IFN production was not altered after treatment with anti-NK mAb (Leu-7 and Leu-11) and complement (not shown).
The effect of exogenous accessory cells was evaluated. Lectin-primed populations had few monocytes and dendritic cells, as assessed by cytology and by surface markers; i.e., there were <1% cells stained with the 3C10 antimonocyte mAb, and <0.1% Ia-rich dendritic cells (24) . The primed T cells did not respond to lectin (Table I ), but addition of plastic adherent cells at a ratio of 1:3 restored the lectin response (not shown). With this background information, we proceeded to analyze the regulation of lymphokine release at the level of specific mRNAs.
Kinetics of lnduction of Several mRNAs During Optimal Stimulation of Lymphokine
Release. The level of several mRNAs was monitored in primed and unprimed T cells that were stimulated with lectin and PMA ( Figs. 1 and 2 ). Northern blotting showed that three mRNAs: actin, /32-microglobulin, and c-myb, were present in the nonstimulated cells and were not increased by lectin/PMA. However, six other mRNAs were induced, c-fos mRNA peaked at 0.5 h and Conditioned medium (15%) was derived from lympboblasts (10 6 cells]ml) that had been cultured for 2 h with different stimuli. After 2 h, all stimuli except IL-2 were removed, and the incubation was continued for 18 h. IL-2 activity was measured in a bioassay using Con A blasts as responders, while IFN-~" was measured in an RIA. Stimuli for Lymphokine and Nonlymphokine mRNas, and Effects of CsA. The highest levels of IL-2 and IFN mRNAs were induced when lectin and PMA were added in concert (Fig. 3) , just like the release of these lymphokines (Table I) . Lectin or PMA alone induced little or no response in either IL-2 or IFN mRNA.
In contrast, the induction of other genes (c-fos, c-myc, IL-2-R) required only lectin or PMA, and no synergism was observed (Fig. 3) . The mitogenic OKT3 mAb had no independent effect on any of the mRNAs we studied, but was markedly synergistic with PMA in inducing IL-2 and IFN mRNAs (Fig. 4) . c-fos, c-myc, and IL-2-R again responded to PMA alone, and there was no synergism with OKT3.
CsA is known (1-4) to inhibit IL-2 gene transcription, and indeed blocked the induction of both IL-2 and IFN mRNAs (Figs. 2-4) . CsH was not inhibitory (Fig. 5) . CsA also blocked, although not completely, the induction ofc-myc (Figs. 2-4) as was also noted by Reed et al. (25) . The addition of CsA for 1 h before stimulation with lectin or PMA did not lead to a complete block of c-myc induction. In contrast, CsA did not alter the mRNA levels of other nonlymphokine genes (c-fos, and HSP) in response to either lectin, PMA, OKT3, or combinations thereof (Figs. 2-4) . CsA reduced IL-2-R mRNA levels little (Figs.  2 and 4) or not at all (Fig. 3) .
The northern blotting results were pursued with nuclear transcription assays. As expected from the prior work of Kronke et al. (26) , the induction of IL-2 mRNA by PMA and PHA was at the level of transcription, and was CsA sensitive (Fig. 6 ). Increased transcription of c-myc was also apparent and was blocked by CsA (Fig. 6) . We conclude that the induction of lymphokine mRNAs differs from nonlymphokine mRNAs in the requirement for the concerted action of PMA and either lectin or OKT3, and in sensitivity to CsA, with the exception that c-myc is also CsA sensitive. mRNA Levels in T4 and T8 Subsets. Highly enriched populations of T4+,T8 -and T4-,T8 + cells were prepared by panning, and were stimulated with PHA and PMA in the presence or absence of CsA. IL-2, IFN, and c-myc mRNAs were induced in both subsets, and the induction was CsA sensitive (Fig. 7) .
Effects oflL-2. IL-2 was also evaluated as a stimulus and was found to induce c-myc, HSP and IL-2-R mRNAs (Fig. 8, left) . Peak levels were reached in 5 h, FIGURE 2 . Time course of mRNA accumulation in freshly isolated blood mononuclear cells. The celts were stimulated with 1 t~g/ml PHA and 10 ng/ml PMA in the presence or absence of CsA (1 #g/ml) for the indicated times (h). Total RNA was isolated, size fractionated (70 ug for probing with IL-2 and IFN, and 10/~g for the others) and hybridized to 3~P-labeled probes. Note that the kinetics of expression of lymphokine and c-myc genes are slower than those observed in T blasts (Fig. 1) , but again are similar to one another and blocked by CsA. FIGURE 3. Expression of mRNAs for lymphokine and nonlymphokine genes after PHA and PMA stimulation; effects of CsA. T blasts were cultured in the presence of PHA (1 #g/ml), PMA (10 ng/ml), or IL-2 (300 U/ml), with or without CsA (1 #g/ml). After 30 min (c-fos) or 5 h (all other probes), total RNA was extracted, electrophoresed in 1% agarose gel (20 #g RNA for probing with 1L-2 and IFN; 10 #g for the others), and hybridized with s2P-labeled probes. Note that IL-2 and 1FN mRNAs require the concerted action of PMA and PHA, whereas the other mRNAs respond to either stimulus; and CsA blocks the induction of lymphokine and c-myc mRNAs. A, control; B, PHA; C, PHA + CsA; D, PMA; E, PMA + CsA; F, PHA + PMA; G, PHA + PMA + CsA; H, IL-2; I, IL-2 + CsA.
and remained elevated for >24 h (not shown). IL-2 was a less effective inducer than PHA/PMA, but only a fraction of our mononuclear populations (30-50% of the cells) stained clearly with the anti-TAC mAb against IL-2-R (not shown). IL-2 induced a small IFN mRNA response, and this induction was not blocked by CX (Fig. 8, right) . IL-2 failed to induce its own mRNA (Fig. 8, right) . CsA did not inhibit any of the responses to IL-2 (Fig. 8) . Therefore, IL-2 primarily stimulates nonlymphokine mRNAs in T cells, and all the responses are CsA insensitive, including that of c-myc.
Effects of CX. Prior studies had indicated that the protein synthesis inhibitor CX did not alter lymphokine mRNA levels if applied with the mitogen, but did block the downregulation of IL-2 mRNA that occurs at later time points (6, 7). We tested whether CsA interfered with the CX effect. CX did not alter mRNA levels when given during the first 4 h of mitogen restimulation (Fig. 8, right) . If CX was applied at 4-8 h, both IL-2 and c-myc mRNAs were increased relative to control, or more precisely, the endogenous downregulation of these mRNAs did not occur (Fig. 9 ). HSP and IL-2-R mRNAs were not influenced by CX at FIGURE 4. Increase in mRNAs after stimulation with OKT3 mAb and PMA; effects of CsA. Human T lymphoblasts were cultured in the presence of OKT3 (25 ng/ml), PMA (10 ng/ml), and CsA (1 #g/ml) added singly or in concert. After 30 rain (c-los) or 5 h (all others), total RNA was extracted (20 t~g of RNA for probing with IL-2 and IFN; 10 gg for the others) and hybridized with s~P-labeled probes. Note that OKT3 had no effect by itself on mRNA levels, and that CsA primary altered the induction of lymphokine and c-myc mRNAs.
this time (Fig. 9) . If CsA was applied from 4 -8 h, IL-2 and c-myc m R N A s were again markedly reduced, but when CX was also present, higher levels o f m R N A were found (Fig. 9 , right lane). T h e r e f o r e , there appears to be a CX-sensitive step that develops several hours after T cell stimulation and leads to a lowering of IL-2 and c-myc mRNAs. CsA does not seem to inhibit this pathway for increased lymphokine m R N A .
Discussion
T h e availability o f a large n u m b e r o f D N A probes has made it possible to monitor the polyclonal stimulation o f T cells at the level o f several specific mRNAs. T h e panel we used detected the m R N A s for two lymphokines, IL-2 and IFN, which are major differentiated products o f T cells; three protoonco-FIGURE 5. Lack of an effect of the cyclosporin analog CsH. Human T blasts were cultured in the presence of PHA (1 ug/ml) and PMA (I 0 ng/ml), with or without CsA or CsH (1 #g/ml) for 5 h. Serial dilutions of total RNA were applied to nitrocellulose using a BioRad dot blot apparatus and hybridized with s2p-labeled IL-2 cDNA probe. genes, c-myb, c-myc, a n d c-fos, which e n c o d e p r o t e i n s that localize to the nucleus a f t e r s t i m u l a t i o n o f m a n y cell types (10, 32, 34) ; H S P -7 0 , p r e v i o u s l y d e t e c t e d in cells i n f e c t e d with a d e n o v i r u s o r e x p o s e d to h e a t shock (35); a n d IL-2-R, which is e x p r e s s e d in T cells (26, 36) a n d o t h e r leukocytes. T h r e e p a r a m e t e r s w e r e m o n i t o r e d :
Stimuli. T h e e x p r e s s i o n o f l y m p h o k i n e m R N A s r e q u i r e d distinct e x o g e n o u s stimuli. F o r IL-2 a n d I F N , o p t i m a l m R N A i n d u c t i o n r e q u i r e d the c o n c e r t e d FIGURE 7 . Induction of mRNAs in T cell subsets. Human T blasts (taken after 5 d of culture in lectin) were coated with supernatants from the OKT4 or OKT8 hybridoma lines. The cells were washed and spun onto Petri dishes coated with affinity-purified Fab2 fragment of goat anti-mouse Ig. The nonbound cells were harvested and shown to be highly enriched in T4-or T8-bearing cells (>95% pure). The subsets were stimulated with PHA and PMA with or without CsA for 5 h. Cytoplasmic RNA was extracted with phenol/chloroform (17), and 10 #g was blotted to nitrocellulose. The filters were hybridized with *2P-labeled probes and exposed for autoradiography for 3 d. Note that the T cell subsets show similar induction of IL-2, IFN, c-myc, and HSP, and similar sensitivity to CsA. action of PMA and either lectin or OKT3 mAb (Figs. 3-4) . This finding on primary T cells was similar to that reported for lymphokine mRNA in T cell lines (2) , and for lymphokine secretion (20, 21) . There was little and sometimes no increase in lymphokine mRNA when the T cells were triggered independently by lectin, PMA, OKT3, or IL-2. In contrast, several nonlymphokine mRNAs:
IL-2-R, c-myc, and c-fos, were induced to high levels by either lectin, PMA, or IL-2. All these findings seemed to represent direct effects on T cells, since our populations had few accessory cells by the criteria of direct examination and an absence of lectin responsiveness (Table I) . Furthermore, the responses were similar in T4 and T8 subsets (Fig. 7) .
The requirement for both OKT3 and PMA during polyclonal activation must have a counterpart in the physiologic or antigenic stimulation of T cells. The T3 complex is associated with the T cell receptor for antigen and MHC (37) , and binding of OKT3 mediates a calcium influx (38, 39) . One could reason that this influx, and possibly antigen binding, do not independently lead to lymphokine C O N T R O L OF LYMPHOKINE mRNA LEVELS FIGURE 8. Effect of rlL-2 on the expression of inducible mRNAs. T blasts were cultured 6 h with 300 U/ml rIL-2 or with PHA (1 ttg/ml) and PMA (10 ng/ml) in the presence or absence of 1 ~tg/ml CsA. CX was added at 5/zg/ml at the onset of some of the cultures (right). Note that IL-2 induces a significant, but CsA-insensitive increase in c-myc, HSP, and IL-2-R mRNAs (relative to P H A / P M A ; left), whereas 1L-2 has little (IFN) or no (IL-2) effect on lymphokine mRNAs (right).
gene expression or to the induction of several genes that are presumably required for cell division, i.e., comyc, c-fos, and IL-2-R. These findings are reminiscent of the failure of antigen to independently trigger primary antigen-specific responses like the mixed leukocyte reaction and T-dependent antibody formation. Instead, primary stimulation requires that antigen be presented in association with dendritic cells, and the response is accompanied by the initiation of lymphokine production (40) . We are therefore testing whether dendritic cells trigger lymphokine mRNAs in antigen-specific systems to a comparable extent to that seen with mitogens (OKT3 or PHA) plus PMA.
Kinetics. The application of PMA led to the induction of several genes, but the kinetics were very different, c-fos appeared early and briefly in stimulated T cells, as has been observed in other cell types (32, 33) . c-myc was expressed shortly after c-fos, and IL-2-R mRNA appeared much later (Figs. 1 and 2 ). Whereas the onset of the PMA response likely involves the activation of protein kinase C, the FIGURE 9. Effect of CX on the levels of IL-2 and nonlymphokine mRNA. T blasts were cultured with PHA (1 #g/ml) and PMA (10 ng/ml). CX (10 #g/ml) and/or CsA (1 #g/ml) were added at the indicated times. Cells were harvested after 4 or 8 h of culture. Total RNA was extracted, separated in agarose gel, and hybridized with s~p-labeled probes. Note that c-myc and IL-2 mRNA levels fall between 4 and 8 h (lanes 2 and 3) . This decrease is blocked by CX even in the presence of CsA (lanes 5 and 7). s u b s e q u e n t steps l e a d i n g to c-fos, c-myc, a n d I L -2 -R e x p r e s s i o n m u s t d i f f e r to e x p l a i n such d i f f e r e n t kinetics. E x p r e s s i o n o f I L -2 a n d I F N m R N A s seems m o r e r a p i d t h a n e x p r e s s i o n o f I L -2 -R (Fig. 2) . T h i s suggests t h a t T cells can b e g i n p r o d u c i n g t h e i r d i f f e r e n t i a t e d p r o d u c t s b e f o r e b e c o m i n g fully c o m p e t e n t for cell g r o w t h . T h e r e f o r e , i m m u n o s u p p r e s s i v e r e g i m e s that a r e d i r e c t e d to the IL-2-R, such as application of anti-IL-2-R antibodies, may not efficiently ablate T cell function, since lymphokines could still be formed.
CsA. The profound immunosuppressive effects of CsA on T cells are well known, but it is only recently that a selective effect on lymphokine mRNA has been stressed (1-4) . An exception appears to be the c-myc gene, which is believed to encode a nuclear binding protein, and which can be induced in many cell types (41) . We are testing whether CsA will block c-myc expression in non-T cells, since this could lead to nonspecificity in its clinical action.
The sensitivity of c-myc to CsA is most useful in analyzing the mechanism of action of this drug. It is difficult to argue that CsA blocks signalling at the cell surface, since it is apparent that CsA blocks the c-myc response to PMA or lectin, but not the response of other genes (c-fos, IL-2-R) to PMA or to lectin. CsA also does not block the IL-2-induced increase in c-myc mRNA, or the smaller increase in IFN mRNA. The fact that c-myc and lymphokine mRNAs also exhibited similar kinetics prompts our working hypothesis that CsA acts on a transcriptional control site that is shared by lymphokine and c-myc genes, either by binding directly to this region or by inhibiting the function of a control factor acting thereon.
Summary
Northern and dot blotting with a panel of DNA probes were used to monitor the levels of specific mRNAs in mitogen-stimulated human T cells. The induction of IL-2 and IFN mRNAs required the synergistic action of PMA and either PHA or OKT3 mAb. In contrast, several nonlymphokine genes, the protooncogenes c-fos and c-myc, and the IL-2-R gene, were induced by either PHA or PMA alone. PHA increased the background levels of a 70 kD heat shock protein mRNA, but did not affect the observed background of c-myb mRNA. For all mRNAs that were induced, isolated CD4 and CD8 T cell subsets behaved similarly. Exogenous IL-2 had little (IFN) or no (IL-2) effect on lymphokine mRNAs, but significantly increased c-myc, IL-2-R and heat shock protein mRNAs. Therefore, the stimuli for lymphokine mRNAs differed from those required for several inducible nonlymphokine genes.
IL-2 and IFN mRNAs exhibited some important similarities with c-myc, however. The levels of IL-2, IFN, and c-myc mRNA followed similar kinetics, peaking at 3 h in restimulated blasts and at 12 h in unstimulated T cells. The subsequent downregulation of iymphokine and c-myc mRN As was retarded by cycloheximide. The induction of IL-2, IFN, and c-myc mRNAs was blocked by the immunosuppressive drug CsA, but not by the inactive analog CsH, and this block occurred at the level of nuclear transcription. Since the exogenous stimuli for lymphokine and c-myc gene expression differ, we suggest that intracellular controls must be shared to account for the similarities in their kinetics of expression and CsA sensitivity.
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